Amgen's $1.154 Billion Trading Day Ranks 95th as Analysts Boost Price Targets

On May 12, 2025, Amgen's trading volume reached $1.154 billion, ranking 95th in the day's stock market activity. The company's stock price increased by 3.35%.

Amgen is scheduled to present at the Bank of America Merrill Lynch Global Healthcare Conference. This event is expected to provide insights into the company's strategic direction and financial performance, potentially influencing investor sentiment and stock price movements.

Additionally, Mizuho has raised its price target for Amgen to $280, reflecting a positive outlook on the company's growth prospects. This adjustment in price target is likely to bolster investor confidence and contribute to the stock's upward trajectory.

Bank of America has also increased its price objective for Amgen from $275 to $294, further underscoring the bullish sentiment surrounding the company. This revision, along with the upcoming conference presentation, positions Amgen favorably in the eyes of investors.